1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid
|
|
|
- CAS-Nr.
- 1163685-30-0
- Englisch Name:
- 1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid
- Synonyma:
- Rabeprazole USP RC A;Lansoprazole Impurity 13;ansoprazole Impurity M-1;Rabeprazole EP Impurity C;Lansoprazole impurity 10027-0926;Rabeprazole EP Impurity C (Acid);Rabeprazole sodium EP Impurity C;Rabeprazole-USP-RC-A (free acid);sodium 1-(1H-benzo[d]imidazol-2-yl)-;Dextrorotation lansoprazole Impurity-1
- CBNumber:
- CB62507859
- Summenformel:
- C14H11N3O3
- Molgewicht:
- 269.26
- MOL-Datei:
- 1163685-30-0.mol
|
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Eigenschaften
- Siedepunkt:
- 506.9±60.0 °C(Predicted)
- Dichte
- 1.506±0.06 g/cm3(Predicted)
- storage temp.
- -20°C
- L?slichkeit
- Water (Slightly)
- pka
- -1.41±0.20(Predicted)
- Aggregatzustand
- Solid
- Farbe
- Light Yellow
- Major Application
- pharmaceutical (small molecule)
- InChI
- 1S/C14H11N3O3/c1-8-11(18)6-7-17(12(8)13(19)20)14-15-9-4-2-3-5-10(9)16-14/h2-7H,1H3,(H,15,16)(H,19,20)
- InChIKey
- CBHQVBYUZFZICT-UHFFFAOYSA-N
- SMILES
- [n]3(c(c([c](cc3)=O)C)C(=O)O)c1[nH]c2c(n1)cccc2
Sicherheit
| WGK Germany |
WGK 3 |
|
|
| Speicherklasse |
11 - Combustible Solids |
|
|
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
Pale Yellow Solid
Verwenden
Rabeprazole (R070500) impurity. A degradation product formed in stressed tablets of Rabeprazole sodium.
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 65)Lieferanten
- 1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid
- 1-(1H-BenziMidazol-2-yl)-1,4-dihydro-3-Methyl-4-oxo-2-pyridinecarboxylic Acid
- Rabeprazole USP RC A
- Rabeprazole EP Impurity C
- Rabeprazole-USP-RC-A (free acid)
- sodium 1-(1H-benzo[d]imidazol-2-yl)-
- Lansoprazole Impurity 13
- 1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid (>75%)
- 1-(1H-Benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid (>
- Lansoprazole impurity 10027-0926
- 2-Pyridinecarboxylic acid, 1-(1H-benzimidazol-2-yl)-1,4-dihydro-3-methyl-4-oxo-
- Rabeprazole Impurity 21（Rabeprazole EP Impurity C）
- Rabeprazole USP Related Compound A Sodium salt
- Rabeprazole EP Impurity C (Acid)
- Rabeprazole EP Impurity C/ Rabeprazole Related Compound A
- sodium 1-(1H-benzo[d]imidazol-2-yl)-3-methyl-4-oxo-1,4-dihydropyridine-2-carboxylate? (Rabeprazole Impurity）
- Dextrorotation lansoprazole Impurity-1
- ansoprazole Impurity M-1
- Rabeprazole sodium EP Impurity C
- 1163685-30-0
- Aromatics
- Heterocycles
- Impurities
- Intermediates & Fine Chemicals
- Pharmaceuticals
- Aromatics, Heterocycles, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
